Type 2 Diabetes Trial, Recruiting NCT02861781 Sponsor: University Hospital, Montpellier Condition: Type 2 Diabetes
Back to Type 2 Diabetes

Type 2 Diabetes Trial, Recruiting

NCT02861781
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are between 18 and 65 years old at the time of their surgery
  • People with a Body Mass Index (BMI) over 35 (a measure of body weight relative to height)
  • People who have been approved by their doctor for weight-loss surgery, specifically sleeve gastrectomy or gastric bypass
  • People who fall into one of three specific groups: those with Type 2 diabetes, those without diabetes but with signs of insulin resistance (the body not responding well to insulin), or those without diabetes and with normal insulin sensitivity (confirm with trial site for which group applies)
  • People who are willing and able to provide written agreement to participate

Who may not be able to join:

  • People who are considered vulnerable under French public health law, or who are legally protected adults, or who are unable to give their own consent
  • People who are unable to understand the purpose of the study or communicate with the research team
  • People who are not enrolled in a social security system
  • People who have previously had weight-loss surgery (other than a lap-band procedure)
  • People whose blood tests show infection with Hepatitis B, Hepatitis C, or HIV
  • People who have or recently had (within the past 3 months) an inflammatory, infectious, or autoimmune condition
  • People who have had cancer within the past 5 years, or whose cancer is not considered fully treated
  • People currently using or who have used steroids or anti-inflammatory medications (NSAIDs) within 8 days before surgery
  • People with alcohol abuse or addiction
  • People who are unlikely to follow the study procedures as required
  • People who have a type of diabetes other than Type 2
  • People whose weight-loss surgery is cancelled
  • People from whom tissue samples cannot be collected during surgery

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
2 February 2016
Est. completion
1 September 2028

Where this trial is recruiting

🇫🇷 France

Primary endpoints

comparison of metabolites; comparison of proteins levels; comparison of miRNA

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov